Difference between revisions of "Goncalo Abecasis"
| Line 1: | Line 1: | ||
[[Image:GoncaloAbecasis.jpg|300px|right]] | [[Image:GoncaloAbecasis.jpg|300px|right]] | ||
| + | |||
| + | Dr. Abecasis is the Felix Moore Collegiate Professor of Biostatistics at the University of Michigan School of Public Health. He is also the Director of the University of Michigan Genomics Initiative. Dr. Abecasis' research focuses on the development of study designs, statistical tools and computational methods that enable comprehensive studies of genetic variation and its connections to human disease. Software and algorithms developed by Dr. Abecasis are used in human genetic studies around the world. He has made important contributions to our understanding of patterns of genetic variation across the genome, its relationship to complex traits and diseases, and developed algorithms that enable analysis of large challenging datasets. He is currently deploying next-generation sequencing and genotyping technologies to study the genomes of thousands of individuals. | ||
== See Also == | == See Also == | ||
[[Goncalo Abecasis: Interview with Christiana Fogg]] | [[Goncalo Abecasis: Interview with Christiana Fogg]] | ||
Revision as of 21:08, 15 May 2013
Dr. Abecasis is the Felix Moore Collegiate Professor of Biostatistics at the University of Michigan School of Public Health. He is also the Director of the University of Michigan Genomics Initiative. Dr. Abecasis' research focuses on the development of study designs, statistical tools and computational methods that enable comprehensive studies of genetic variation and its connections to human disease. Software and algorithms developed by Dr. Abecasis are used in human genetic studies around the world. He has made important contributions to our understanding of patterns of genetic variation across the genome, its relationship to complex traits and diseases, and developed algorithms that enable analysis of large challenging datasets. He is currently deploying next-generation sequencing and genotyping technologies to study the genomes of thousands of individuals.
